血小板粘着の開始は,フィブリノゲンへの収束またはフォン・ウィレブランド因子への転位による
B Savage1, E Saldívar, Z M Ruggeri
1Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, La Jolla, California 92037, USA.
Cell
|January 26, 1996
まとめ
血小板の粘着には2つのメカニズムが含まれます:インテグリンアルファIIbβ3は,即座に,しかし低シーア停止,および高シーア運動と最終的な停止のためのグリコプロテインIbアルファ. この二重の機能は,血栓形成の鍵です.
科学分野:
- バイオメディカルエンジニアリング
- 血液学 ヘマトロジ
- 細胞生物学 細胞生物学
背景:
- 血小板の血栓形成表面への粘着は,血液静止と血栓形成に不可欠です.
- 流れ下で血小板の結合の分子メカニズムを理解することは,抗血栓治療の開発に不可欠です.
研究 の 目的:
- 流動性血小板粘着の開始におけるインテグリンアルファIIbβ3とグリコプロテインIbアルファの異なる役割と相互作用を明らかにする.
- 壁切断率の変動における各固着メカニズムの効率と限界を特徴づける.
主な方法:
- 制御されたシーアフロー条件下で固定されたフィブリノゲンとフォン・ウィレブランド因子に対する血小板粘着を調査した.
- 血小板表面相互作用に対するインテグリンアルファIIbβ3とグリコプロテインIbアルファの寄与を分析した.
主要な成果:
- インテグリンアルファIIbβ3はフィブリノゲンに対する血小板の急速な停止を媒介するが,600-900s-1.0未満のシーアレートに限られている.
- グリコプロテインIbアルファは,6000s-1を超えるシーア速度でフォン・ウィレブランド因子との持続的な血小板相互作用を促進します.
- 活性化されたインテグリンアルファIIbβ3は,その後,高切断条件下でフォン・ウィレブランド因子による血小板を止めることができる.
結論:
- 切断速度の依存性と分子相互作用によって異なる2つの異なる粘着機構は,血小板が血栓形成表面との最初の接触を制御します.
- インテグリンアルファIIbβ3とグリコプロテインIbααの von Willebrand因子への結合は,特に高流量条件下で,効果的な血栓形成に不可欠です.
さらに関連する動画
関連する概念動画
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:05Introduction to Hemostasis
14.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.5K
01:22Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
01:09Coagulation
8.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K
01:16Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K